SpectraCure Management

Management criteria checks 3/4

SpectraCure's CEO is Masoud Khayyami, appointed in Jan 2023, has a tenure of 1.83 years. directly owns 21.45% of the company’s shares, worth SEK34.34M. The average tenure of the management team and the board of directors is 4.8 years and 2.5 years respectively.

Key information

Masoud Khayyami

Chief executive officer

SEK 300.0k

Total compensation

CEO salary percentagen/a
CEO tenure1.8yrs
CEO ownership21.5%
Management average tenure4.8yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

Jul 31
SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That SpectraCure (STO:SPEC) Will Use Its Cash Wisely

Feb 23
We're Hopeful That SpectraCure (STO:SPEC) Will Use Its Cash Wisely

We're Not Very Worried About SpectraCure's (STO:SPEC) Cash Burn Rate

Nov 09
We're Not Very Worried About SpectraCure's (STO:SPEC) Cash Burn Rate

Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth

Jul 27
Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth

Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth

Mar 09
Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth

SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

Nov 08
SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

Jul 26
SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans

We Think SpectraCure (STO:SPEC) Can Afford To Drive Business Growth

Mar 19
We Think SpectraCure (STO:SPEC) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About SpectraCure's (STO:SPEC) Cash Burn Situation

Nov 16
Here's Why We're Not Too Worried About SpectraCure's (STO:SPEC) Cash Burn Situation

We Think SpectraCure (STO:SPEC) Can Easily Afford To Drive Business Growth

Aug 03
We Think SpectraCure (STO:SPEC) Can Easily Afford To Drive Business Growth

We're Not Worried About SpectraCure's (STO:SPEC) Cash Burn

Apr 16
We're Not Worried About SpectraCure's (STO:SPEC) Cash Burn

Companies Like SpectraCure (STO:SPEC) Can Afford To Invest In Growth

Jan 01
Companies Like SpectraCure (STO:SPEC) Can Afford To Invest In Growth

CEO Compensation Analysis

How has Masoud Khayyami's remuneration changed compared to SpectraCure's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 23m

Jun 30 2024n/an/a

-SEK 21m

Mar 31 2024n/an/a

-SEK 21m

Dec 31 2023SEK 300kn/a

-SEK 20m

Sep 30 2023n/an/a

-SEK 23m

Jun 30 2023n/an/a

-SEK 23m

Mar 31 2023n/an/a

-SEK 24m

Dec 31 2022SEK 300kn/a

-SEK 25m

Sep 30 2022n/an/a

-SEK 25m

Jun 30 2022n/an/a

-SEK 25m

Mar 31 2022n/an/a

-SEK 25m

Dec 31 2021SEK 2mSEK 1m

-SEK 23m

Compensation vs Market: Masoud's total compensation ($USD27.27K) is below average for companies of similar size in the Swedish market ($USD236.52K).

Compensation vs Earnings: Masoud's compensation has been consistent with company performance over the past year.


CEO

Masoud Khayyami (61 yo)

1.8yrs

Tenure

SEK 300,000

Compensation

Dr. Masoud Khayyami, Ph D., serves as Nomination Committee Member of Lumito AB (publ). He is a Founder and serves as Manager at MK Capital AB.He served as Chairman of the Board of Lumito AB (publ) until 2...


Leadership Team

NamePositionTenureCompensationOwnership
Masoud Khayyami
Interim CEO & Director1.8yrsSEK 300.00k21.45%
SEK 34.3m
Henrik Ljung
Chief Financial Officer6.8yrsno datano data
Johannes Swartling
Chief Technology Officer15.8yrsno datano data
Mirjam Johansson
Administrative Managerno datano datano data
Kristina Holst
Head of Clinical Affairs2.8yrsno datano data

4.8yrs

Average Tenure

59yo

Average Age

Experienced Management: SPEC's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Masoud Khayyami
Interim CEO & Director2.5yrsSEK 300.00k21.45%
SEK 34.3m
Brian Wilson
KhayyamiScientific Advisorsno datano datano data
Homer Pien
Independent Director3.5yrsSEK 300.00kno data
Katarina Svanberg
Independent Director21.8yrsSEK 300.00k0.21%
SEK 329.6k
Stephen Hahn
Scientific Advisorno datano datano data
Stephen Bown
Scientific Advisorno datano datano data
Colin Hopper
Scientific Advisorno datano datano data
Tomas Kramar
Independent Director2.5yrsSEK 300.00k0.026%
SEK 41.2k
Jorgen Wennberg
Independent Chairman of the Board2.5yrsSEK 500.00k1.43%
SEK 2.3m
Jesper Freij
Independent Director2.5yrsSEK 600.00k0.0046%
SEK 7.4k

2.5yrs

Average Tenure

65.5yo

Average Age

Experienced Board: SPEC's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.